Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions.
Leoni
V
V
Università Campus Bio-Medico Via Emilio Longoni, 83 00155 Rome Italy. d.santini@unicampus.it
Santini
D
D
Vincenzi
B
B
Grilli
C
C
Onori
N
N
Tonini
G
G
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D011929:Razoxane / Q000008:administration & dosage / Q000009:adverse effects*
D000970:Antineoplastic Agents; D011929:Razoxane